A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
This study is a single arm, non-randomized, open label phase 2 international, multicenter
clinical trial to evaluate preliminary efficacy and safety in subjects with relapsed or
refractory lymphoma.